Allergies News and Research

Latest Allergies News and Research

Emory-led consortium receives NIH grant to develop effective HIV/AIDS vaccine

A consortium of leading vaccine researchers at Emory University and partner institutions has received a National Institutes of Health (NIH) grant aimed at developing an effective HIV/AIDS vaccine.

19 Jul 2011

Facts and myths about bed bugs

Bed bugs are back. Since 2000, bed bug infestations have risen 81 percent, according to The National Pest Management Association. This resurgence has consumers nationwide on high alert, seeking information on the pests and how they can protect themselves.

18 Jul 2011

Study recommends short and simple HIV consent forms

An in-depth review of consent forms provided to volunteers for HIV/AIDS research in the United States and abroad about study procedures, risks and benefits has found that the forms were extremely long and used wording that may have been complex enough to hinder full understanding, according to bioethicists at The Johns Hopkins University.

16 Jul 2011

Tips for preventing allergy during ragweed pollen season

Feel like there's no end in sight when it comes to fall allergy misery? Blame global warming. Research suggests that with global warming, nasal allergy during the ragweed pollen season - also called hay fever or seasonal allergic rhinitis - lasts up to three weeks longer than it used to, and the further north you live, the longer you have to wait for relief.

16 Jul 2011

Partially hydrolysed whey formula does not prevent allergies in high-risk infants

Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.

15 Jul 2011

Five-year research initiative to cure HIV disease

A team of AIDS experts at Johns Hopkins and other institutions have embarked on a joint five-year research initiative to cure HIV disease by finding ways to completely purge the virus from the body in people already successfully suppressing the virus with antiretroviral drug therapy.

14 Jul 2011

PharmAthene demonstrates 36 month stability of rPA anthrax vaccine program candidate

PharmAthene, Inc. announced today that it has achieved an important program milestone in its recombinant protective antigen (rPA) anthrax vaccine program and demonstrated 36 month stability of its rPA drug product candidate previously produced at Avecia Biologics Laboratories in the United Kingdom. The stability data were prepared utilizing a variety of analytical methods and a well characterized mouse challenge potency assay.

14 Jul 2011

Johns Hopkins receives NHLBI grant to establish two programs in glycosciences

The National Heart, Lung and Blood Institute, one of the National Institutes of Health, has awarded two groups at the Johns Hopkins University School of Medicine each approximately $2.3 million a year for seven years to establish two Programs of Excellence in Glycosciences.

13 Jul 2011

Hypoallergenic dogs not allergen free as claimed: Study

New research shows that the levels of dog allergens don't appear to be very different in houses with hypoallergenic dogs than in those with other dogs.

13 Jul 2011

Rapid method can predict immune responses against flu vaccines

Researchers at the Emory Vaccine Center have developed a method for predicting whether someone will produce high levels of antibodies against a flu shot a few days after vaccination.

12 Jul 2011

UNC receives $32 million federal grant to eradicate HIV infection

Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy.

12 Jul 2011

New research strategy for eradicating HIV from the body

An international team led by researchers from the University of California, San Francisco and the nonprofit Vaccine and Gene Therapy Institute of Port St. Lucie, Fla., has received a major grant from the National Institutes of Health to develop a strategy to eradicate HIV from the body.

12 Jul 2011

Merck researchers to participate in two new collaborative efforts to study HIV latency

Merck, known as MSD outside the United States and Canada, today announced that company researchers will participate in two new collaborative efforts led by the prominent academic institutions of the University of North Carolina (UNC) Chapel Hill and the University of California San Francisco (UCSF) to develop new approaches towards eradicating HIV, the virus that causes AIDS.

12 Jul 2011

Hutchinson Center receives $20M NIH grant to eradicate HIV infection

Whether a stem cell transplant using an HIV-infected person's own genetically modified immune cells can become a cure for the disease is the focus of a new $20 million, five-year research grant award announced today by the National Institutes of Health to Fred Hutchinson Cancer Research Center.

12 Jul 2011

NIAID awards $14 million a year for new HIV research

Three research teams focused on developing strategies that could help to rid the body of HIV are receiving grants totaling more than $14 million a year, for up to five years, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health announced today.

11 Jul 2011

Researchers measure environmental allergen linked with hypoallergenic dogs

Contrary to popular belief, so-called hypoallergenic dogs do not have lower household allergen levels than other dogs.

11 Jul 2011

Flu vaccine against all strains of virus coming soon

A universal flu vaccine, capable of working against all strains, would save lives and money by eliminating the need for the annual jab say experts. Researchers in California and the Netherlands believe they are now a “step closer” to meeting this objective.

10 Jul 2011

Scientists track public health trends through Twitter

Twitter allows millions of social media fans to comment in 140 characters or less on just about anything: an actor's outlandish behavior, an earthquake's tragic toll or the great taste of a grilled cheese sandwich.

8 Jul 2011

Heartworm medication Ivermectin prevents malaria transmission in Africa

A cheap, common heartworm medication that is already being used to fight other parasites in Africa could also dramatically interrupt transmission of malaria, potentially providing an inexpensive tool to fight a disease that kills almost 800,000 people each year, according to a new study published in the July edition of the American Journal of Tropical Medicine and Hygiene.

7 Jul 2011

Levels of urinary eosinophil protein-X may predict future atopy in asymptomatic children

The signs of atopy may be present long before symptoms begin, even in month-old babies, according to a new research study from Denmark. The study found that the level of urinary eosinophil protein-X (u-EPX), a marker of inflammatory cells, in newborn babies was linked to higher risk of allergic sensitization, nasal eosinophilia and eczema at six years.

7 Jul 2011